Beyond chemoresistance, ATAD2 contributes to tumor progression and immune evasion; for instance, in papillary thyroid cancer (PTC), it promotes oncogenic behaviors by activating the PI3K-AKT pathway and regulating the G1/S cell cycle transition [129]. The gene discussed is ATAD2; the disease is thyroid gland papillary carcinoma.